| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NUVL | Nuvalent, Inc. | Director | $265K | Jun 18, 2025 | ||
| VERA | Vera Therapeutics, Inc. | Director | $129K | May 14, 2025 | ||
| KPTI | Karyopharm Therapeutics Inc. | Director | May 28, 2025 | |||
| LVTX | LAVA Therapeutics NV | Director | Nov 13, 2025 | |||
| RYZB | RayzeBio, Inc. | Director | Feb 26, 2024 | |||
| RETA | REATA PHARMACEUTICALS INC | Director | Sep 26, 2023 | |||
| REPL | Replimune Group, Inc. | Director | Apr 1, 2025 | |||
| SRRA | Sierra Oncology, Inc. | Director | Jul 1, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|